Murphy, Middleton, Hinkle & Parker, Inc. Abb Vie Inc. Transaction History
Murphy, Middleton, Hinkle & Parker, Inc.
- $185 Million
- Q3 2024
A detailed history of Murphy, Middleton, Hinkle & Parker, Inc. transactions in Abb Vie Inc. stock. As of the latest transaction made, Murphy, Middleton, Hinkle & Parker, Inc. holds 1,592 shares of ABBV stock, worth $320,310. This represents 0.17% of its overall portfolio holdings.
Number of Shares
1,592
Previous 1,592
-0.0%
Holding current value
$320,310
Previous $273,000
15.02%
% of portfolio
0.17%
Previous 0.16%
Shares
5 transactions
Others Institutions Holding ABBV
# of Institutions
3,783Shares Held
1.28BCall Options Held
13MPut Options Held
9.82M-
Vanguard Group Inc Valley Forge, PA171MShares$34.3 Billion0.57% of portfolio
-
Black Rock Inc. New York, NY136MShares$27.5 Billion0.54% of portfolio
-
State Street Corp Boston, MA77.8MShares$15.7 Billion0.59% of portfolio
-
Jpmorgan Chase & CO New York, NY53.6MShares$10.8 Billion0.81% of portfolio
-
Capital International Investors Los Angeles, CA38.6MShares$7.77 Billion1.4% of portfolio
About AbbVie Inc.
- Ticker ABBV
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,768,099,968
- Market Cap $356B
- Description
- AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...